Institutional investors hold a majority ownership of GRFS through the 61.67% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2017, these large investors purchased a net $885.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VAUGHAN NELSON INVESTMENT MANAGE... Bought 2.7 Million shares of Grifols SA
NATIXIS ASSET MANAGEMENT SA Bought 2.0 Million shares of Grifols SA
THREADNEEDLE ASSET MANAGEMENT LT... Bought 1.9 Million shares of Grifols SA